ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
87 hedge funds and large institutions have $107M invested in Antares Pharma, Inc. in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
97% less call options, than puts
Call options by funds: $9K | Put options by funds: $291K
Holders
87
Holding in Top 10
–
Calls
$9K
Puts
$291K
Top Buyers
| 1 | +$2.57M | |
| 2 | +$1.1M | |
| 3 | +$721K | |
| 4 |
B
Baird
Milwaukee,
Wisconsin
|
+$648K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$457K |
Top Sellers
| 1 | -$7.71M | |
| 2 | -$2.01M | |
| 3 | -$635K | |
| 4 |
WHI
William Harris Investors
Chicago,
Illinois
|
-$508K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$256K |